Matthew Hall
4Patents
1h-index
33Co-inventors
40Inventor score
Filing activity: Jun 21, 2017 → Jul 14, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10954228B2 | 1 H-pyrazol-1-yl-thiazoles as inhibitors of lactate dehydrogenase and methods of use thereof | Chemistry; Metallurgy | 2 | Active |
| US12233051B2 | Treating primary or idiopathic hyperoxaluria with small molecule inhibitors of lactate dehydrogenase | Human Necessities | 0 | Active |
| US11752138B2 | Treating primary or idiopathic hyperoxaluria with small molecule inhibitors of lactate dehydrogenase | Human Necessities | 0 | Active |
| US10836759B2 | Thiazole derivatives useful as mutant IDH1 inhibitors for treating cancer | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.